Anneke helps the UK NSC navigate the complexities of clinical genetics evidence in screening when public expectations about the ability of genetics to predict ill health are running high.
The UK NSC and its partners were updated on work to review the evidence for newborn screening for spinal muscular atrophy at the second meeting of the SMA in-service evaluation partnership board.
New UK NSC guidance explains how the committee decides if action is required to mitigate declared conflicts of interest by stakeholders and members.
The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
SMA screening in-service evaluation clinical pathway group holds its first meeting.
The UK National Screening Committee's (UK NSC's) work to improve the newborn screening evidence base features prominently in the England Rare Diseases Action Plan 2024.
Important factors, roles and responsibilities to consider for anyone wanting to conduct research or evaluation into screening.
The UK NSC is consulting on whether to add the quadruple test to the antenatal screening pathway for Edwards' syndrome.
The third UK NSC web-based seminar focused on the potential benefits and limitations of using polygenic scores to calculate the overall chance of developing a disease or condition.
Bursary winners encourage other screening professionals to look into studying master's level health screening module.